The Biotechnology Innovation Organization (BIO) today announced that Kayothera Inc. is the winner of the Start-up Stadium competition held during BIO Digital in June. Pre-recorded presentation videos submitted by 16 finalists were evaluated by expert judges with...
Kayothera will be presenting on their novel immune oncology pipeline during the week of June 10 at BIO’s annual meeting. Pitches for the Startup Stadium will go live on Thursday followed by voting.
KayoThera has taken part in the NYU Stern Business School Endless Frontier Labs accelerator program since October 2020 to refine the business plan and expand the company trajectory and growth initiatives. This accelerator was exceptionally valuable to the development...
Kayothera founders Dr. Esposito and Dr. Kang as well as Scientific Advisory Board Member Dr. Ganesan today published a perspective on the clinical need for new therapeutics treating advanced cancer patients in Nature Cancer. While many therapies have been developed...
In the cover article of the March issue of Nature Cell Biology, Dr. Mark Esposito and Dr. Yibin Kang announce the discovery of a novel driver of breast and prostate cancer metastasis. This newly discovered organelle is driven by a relatively unknown protein named...
KayoThera will be presenting at this year’s 10th Annual BioNJ Biopartnering Conference. Please join us Tuesday, October 6 & Wednesday, October 7, 2020.
